Predictive Oncology Inc. - Common Stock (POAI)
14.19
+0.51 (3.69%)
NASDAQ · Last Trade: Oct 2nd, 3:48 PM EDT
Predictive Oncology Stock Receives Significant Investor Interest Today – Here Are Two Important Developmentsstocktwits.com
Via Stocktwits · September 30, 2025
Intrigued by the market activity one hour before the close of the markets on Monday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · September 29, 2025
DNA Holdings has strategically advised and invested in a landmark $344.4 million capital deal that sees Nasdaq-listed Predictive Oncology Inc. (NASDAQ: POAI) establishing a pioneering "Strategic Compute Reserve" anchored in Aethir's decentralized GPU network. This transformative agreement, structured as two private placements—including a significant crypto PIPE with in-kind
Via MarketMinute · September 29, 2025
Predictive Oncology Shares Tumble 19% On Reverse Stock Split Announcement – More Details Insidestocktwits.com
Via Stocktwits · September 25, 2025
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Via Chartmill · September 29, 2025
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps.
Via Chartmill · September 29, 2025
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 150 points on Monday. Following the market opening Monday, the Dow traded up 0.19% to 46,333.68 while the NASDAQ rose 0.67% to 22,635.76. The S&P 500 also rose, gaining, 0.42% to 6,671.51.
Via Benzinga · September 29, 2025
Gainers PepGen (NASDAQ: PEPG) stock rose 114.3% to $5.7 during Thursday's regular session. The market value of their outstanding shares is at $87.2 million.
Via Benzinga · September 25, 2025
Gainers PepGen (NASDAQ: PEPG) shares rose 141.0% to $6.41 during Thursday's pre-market session. The market value of their outstanding shares is at $87.2 million.
Via Benzinga · September 25, 2025
Via Benzinga · September 8, 2025
Via Benzinga · September 4, 2025
Via Benzinga · September 2, 2025
Renovaro said the Delaware Court of Chancery had approved an expedited trial schedule for the lawsuit it filed to enforce a binding merger agreement with Predictive Oncology.
Via Stocktwits · May 22, 2025
Via Benzinga · April 4, 2025
Via Benzinga · March 26, 2025
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.
Via Chartmill · March 25, 2025
Stay updated with the latest market activity on Tuesday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.
Via Chartmill · March 25, 2025
Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.
Via Chartmill · March 25, 2025
Via Benzinga · March 25, 2025
The market is buzzing with gapping stocks on Tuesday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill · March 25, 2025
Predictive Oncology shares are trading higher on Tuesday after the company announced it developed predictive models to target various cancer types.
Via Benzinga · March 25, 2025
Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via Chartmill · March 25, 2025
Via Benzinga · March 25, 2025

Predictive Oncology stock is trading higher on Tuesday after the company reported positive results from utilizing artificial intelligence for drug repurposing.
Via Benzinga · February 18, 2025